%20(Flexible%20Poster%20Sign%20(12%20x%2012%20in))%20(1).jpg)
Pharmaverse Podcast
The Pharmaverse is a leadership podcast that brings you exclusive insights from the stars of the Pharma universe. Hosted by Michael Pietrack, a top Pharma and Biotech recruiter, whose team partners with the most recognizable Pharma companies in the industry, as well as the hottest of the emerging Biotechs. In each episode, Michael sits down with influential and innovative leaders in the Pharmaceutical and related industries. Listeners will hear from stars from all sectors of the Pharmaverse and will gain valuable insights to help lead their team or structure their careers. Whether you're a current leader, an aspiring leader, or a leadership enthusiast, the Pharmaverse Podcast has something for you. Tune in and subscribe!
Pharmaverse Podcast
Episode 8: Health Equity and Diversity in Clinical Trials with Camille Pope
Welcome back to the Pharmaverse podcast with Michael Pietrack! We are joined today by Camille Pope, Chief Medical Lead at Acclinate, discusses the importance of diversity in clinical research and the impact of a health equity lens. She highlights regulatory and legal developments in clinical trial diversity and addresses the factors contributing to mistrust and exclusion in clinical trials. Pope also provides insights on how pharmaceutical leaders can engage with underrepresented communities and set up diverse clinical trials. Her leadership tip emphasizes the importance of mastering one's current role and striving for excellence.
🔬 Diversity, inclusion, equity, and health equity are key components in addressing clinical trial diversity.
💊 A health equity lens benefits both patients and pharmaceutical companies by ensuring safe and efficacious drugs for all populations.
📝 Regulatory and legal developments, such as FDA guidance and legislation, mandate pharmaceutical companies to prioritize diversity in clinical trials.
❌ Mistrust and exclusion are significant barriers to diversity in clinical trials, and understanding the historical context and validating community experiences is crucial.
🧠 Biases, assumptions, and lack of education contribute to the lack of diversity in clinical trials and should be addressed.
🤝 Engaging with underrepresented communities requires genuine partnerships, community involvement, and trust-building efforts.
🏢 Internal strategies for setting up diverse clinical trials include collaboration across functional areas and leveraging existing knowledge and resources.
🎯 Leaders should strive for excellence in their current roles and master the necessary skills before seeking new opportunities.
Chapters
00:00 Introduction to Camille Pope and her focus on diversity in clinical research
07:02 Breaking down the acronym DE&I (Diversity, Inclusion, Equity, and Health Equity)
09:33 The impact of health equity lens on patients and pharmaceutical companies
14:47 Regulatory and legal developments in clinical trial diversity
19:03 The importance of addressing mistrust and exclusion in clinical trials
23:07 Other factors contributing to lack of diversity in clinical trials
26:15 Engaging with underrepresented communities as a pharmaceutical leader
29:28 Internal strategies for setting up diverse clinical trials
32:42 Leadership tip: Master your current role and strive for excellence
